FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143745590> ?p ?o ?g. }

• W2143745590 endingPage "E978" @default.
• W2143745590 startingPage "E972" @default.
• W2143745590 abstract "Phosphodiesterase type 5 inhibitors may influence human physiology, health, and performance by also modulating endocrine pathways. We evaluated the effects of a 2-day tadalafil administration on adenohypophyseal and adrenal hormone adaptation to exercise in humans. Fourteen healthy males were included in a double-blind crossover trial. Each volunteer randomly received two tablets of placebo or tadalafil (20 mg/day with a 36-h interval) before a maximal exercise was performed. After a 2-wk washout, the volunteers were crossed over. Blood samples were collected at −30 and −15 min and immediately before exercise, immediately after, and during recovery (+15, +30, +60, and +90 min) for adrenocorticotropin (ACTH), β-endorphin, growth hormone (GH), prolactin, cortisol (C), corticosterone, dehydroepiandrosterone-sulfate (DHEAS), and cortisol binding globulin (CBG) assays. C-to-CBG (free cortisol index, FCI) and DHEAS-to-C ratios were calculated. Exercise intensity, perceived exertion rate, O 2 consumption, and CO 2 and blood lactate concentration were evaluated. ACTH, GH, C, corticosterone, and CBG absolute concentrations and/or areas under the curve (AUC) increased after exercise after both placebo and tadalafil. Exercise increased DHEAS only after placebo. Compared with placebo, tadalafil administration reduced the ACTH, C, corticosterone, and FCI responses to exercise and was associated with higher β-endorphin AUC and DHEAS-to-C ratio during recovery, without influencing cardiorespiratory and performance parameters. Tadalafil reduced the activation of the hypothalamus-pituitary-adrenal axis during exercise by probably influencing the brain's nitric oxide- and cGMP-mediated pathways. Further studies are necessary to confirm our results and to identify the involved mechanisms, possible health risks, and potential clinical uses." @default.
• W2143745590 created "2016-06-24" @default.
• W2143745590 creator A5013196481 @default.
• W2143745590 creator A5030738325 @default.
• W2143745590 creator A5039910189 @default.
• W2143745590 creator A5045757250 @default.
• W2143745590 creator A5045883297 @default.
• W2143745590 creator A5062130972 @default.
• W2143745590 creator A5063939488 @default.
• W2143745590 creator A5065700583 @default.
• W2143745590 creator A5073105559 @default.
• W2143745590 creator A5083321289 @default.
• W2143745590 date "2012-04-15" @default.
• W2143745590 modified "2023-10-13" @default.
• W2143745590 title "The phosphodiesterases type 5 inhibitor tadalafil reduces the activation of the hypothalamus-pituitary-adrenal axis in men during cycle ergometric exercise" @default.
• W2143745590 cites W1541053809 @default.
• W2143745590 cites W1592526908 @default.
• W2143745590 cites W1969412681 @default.
• W2143745590 cites W1973363781 @default.
• W2143745590 cites W1974167172 @default.
• W2143745590 cites W1976833226 @default.
• W2143745590 cites W1977270906 @default.
• W2143745590 cites W1979672490 @default.
• W2143745590 cites W1982802479 @default.
• W2143745590 cites W1984659363 @default.
• W2143745590 cites W1990800322 @default.
• W2143745590 cites W1991657036 @default.
• W2143745590 cites W1996120009 @default.
• W2143745590 cites W2000497804 @default.
• W2143745590 cites W2001183947 @default.
• W2143745590 cites W2004008756 @default.
• W2143745590 cites W2010543408 @default.
• W2143745590 cites W2018818730 @default.
• W2143745590 cites W2018858941 @default.
• W2143745590 cites W2022602452 @default.
• W2143745590 cites W2025862307 @default.
• W2143745590 cites W2029049173 @default.
• W2143745590 cites W2029140723 @default.
• W2143745590 cites W2035514405 @default.
• W2143745590 cites W2035799822 @default.
• W2143745590 cites W2040032672 @default.
• W2143745590 cites W2052006041 @default.
• W2143745590 cites W2056221913 @default.
• W2143745590 cites W2061808264 @default.
• W2143745590 cites W2062013602 @default.
• W2143745590 cites W2068239827 @default.
• W2143745590 cites W2074302538 @default.
• W2143745590 cites W2076507733 @default.
• W2143745590 cites W2086944543 @default.
• W2143745590 cites W2087887784 @default.
• W2143745590 cites W2091088413 @default.
• W2143745590 cites W2118905420 @default.
• W2143745590 cites W2120543791 @default.
• W2143745590 cites W2122252112 @default.
• W2143745590 cites W2123154253 @default.
• W2143745590 cites W2128567013 @default.
• W2143745590 cites W2131738855 @default.
• W2143745590 cites W2139093186 @default.
• W2143745590 cites W2142623609 @default.
• W2143745590 cites W2145882636 @default.
• W2143745590 cites W2150734066 @default.
• W2143745590 cites W2159266727 @default.
• W2143745590 cites W2163362824 @default.
• W2143745590 cites W2167543377 @default.
• W2143745590 cites W2171978810 @default.
• W2143745590 doi "https://doi.org/10.1152/ajpendo.00573.2011" @default.
• W2143745590 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22318947" @default.
• W2143745590 hasPublicationYear "2012" @default.
• W2143745590 type Work @default.
• W2143745590 sameAs 2143745590 @default.
• W2143745590 citedByCount "16" @default.
• W2143745590 countsByYear W21437455902012 @default.
• W2143745590 countsByYear W21437455902013 @default.
• W2143745590 countsByYear W21437455902014 @default.
• W2143745590 countsByYear W21437455902015 @default.
• W2143745590 countsByYear W21437455902016 @default.
• W2143745590 countsByYear W21437455902017 @default.
• W2143745590 countsByYear W21437455902018 @default.
• W2143745590 countsByYear W21437455902019 @default.
• W2143745590 countsByYear W21437455902020 @default.
• W2143745590 countsByYear W21437455902022 @default.
• W2143745590 crossrefType "journal-article" @default.
• W2143745590 hasAuthorship W2143745590A5013196481 @default.
• W2143745590 hasAuthorship W2143745590A5030738325 @default.
• W2143745590 hasAuthorship W2143745590A5039910189 @default.
• W2143745590 hasAuthorship W2143745590A5045757250 @default.
• W2143745590 hasAuthorship W2143745590A5045883297 @default.
• W2143745590 hasAuthorship W2143745590A5062130972 @default.
• W2143745590 hasAuthorship W2143745590A5063939488 @default.
• W2143745590 hasAuthorship W2143745590A5065700583 @default.
• W2143745590 hasAuthorship W2143745590A5073105559 @default.
• W2143745590 hasAuthorship W2143745590A5083321289 @default.
• W2143745590 hasConcept C126322002 @default.
• W2143745590 hasConcept C134018914 @default.
• W2143745590 hasConcept C142724271 @default.
• W2143745590 hasConcept C204787440 @default.
• W2143745590 hasConcept C27081682 @default.
• W2143745590 hasConcept C2776768464 @default.

• next